How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
出版年份 2016 全文链接
标题
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
作者
关键词
Basal insulin peglispro, Pharmacokinetics, Pharmacodynamics, Type 2 diabetes, Efficacy, Hypoglycemia
出版物
Diabetes Therapy
Volume 8, Issue 1, Pages 9-22
出版商
Springer Nature
发表日期
2016-11-28
DOI
10.1007/s13300-016-0214-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis
- (2016) Byron J. Hoogwerf et al. Cardiovascular Diabetology
- Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
- (2016) Henry Ginsberg et al. DIABETES OBESITY & METABOLISM
- Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4
- (2016) T. Blevins et al. DIABETES OBESITY & METABOLISM
- Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial
- (2016) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
- (2016) Julio Rosenstock et al. DIABETES OBESITY & METABOLISM
- Comment on Pellegrinelli et al. Human Adipocytes Induce Inflammation and Atrophy in Muscle Cells During Obesity. Diabetes 2015;64:3121–3134
- (2015) Cedric Moro et al. DIABETES
- LY2605541--A Preferential Hepato-Specific Insulin Analogue
- (2014) S. Madsbad DIABETES
- Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
- (2014) Robert R. Henry et al. DIABETES CARE
- Single-dose pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 in healthy subjects
- (2014) Vikram P. Sinha et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
- (2013) M. C. Moore et al. DIABETES
- PEGylated insulin Lispro, (LY2605541)-a new basal insulin analogue
- (2013) T. M. Caparrotta et al. DIABETES OBESITY & METABOLISM
- Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus
- (2013) V. P. Sinha et al. DIABETES OBESITY & METABOLISM
- Will the next generation of basal insulins offer clinical advantages?
- (2013) A. J. Garber DIABETES OBESITY & METABOLISM
- Basal insulin analogues in the management of diabetes mellitus: what progress have we made?
- (2013) David R. Owens et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study
- (2012) J. Rosenstock et al. DIABETES CARE
- A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes
- (2012) R. M. Bergenstal et al. DIABETES CARE
- Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes
- (2012) Katherine Esposito et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
- (2011) Allan Vaag et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Multifaceted Determinants for Achieving Glycemic Control: The International Diabetes Management Practice Study (IDMPS)
- (2008) J. C.N. Chan et al. DIABETES CARE
- Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study
- (2008) A. Dornhorst et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now